BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND CALR, ENSG00000179218, 811, P27797, SSA, RO, FLJ26680, cC1qR AND Clinical Outcome
4 results:

  • 1. The impact of diabetes mellitus on clinical outcomes following chemotherapy for the patients with pancreatic cancer: a meta-analysis.
    Ma J; Wang J; Ge L; Long B; Zhang J
    Acta Diabetol; 2019 Oct; 56(10):1103-1111. PubMed ID: 31069497
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Assessment of clinical outcomes of advanced hilar cholangiocarcinoma.
    Chen KJ; Yang FC; Qin YS; Jin J; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):155-162. PubMed ID: 29636302
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Plasma chromogranin A response to octreotide test: prognostic value for clinical outcome in endocrine digestive tumors.
    Massironi S; Conte D; Sciola V; Spampatti MP; Ciafardini C; Valenti L; Rossi RE; Peracchi M
    Am J Gastroenterol; 2010 Sep; 105(9):2072-8. PubMed ID: 20372113
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Management of cancer of the ampulla of Vater: does local resection play a role?
    Lindell G; Borch K; Tingstedt B; Enell EL; Ihse I
    Dig Surg; 2003; 20(6):511-5. PubMed ID: 14506332
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.